Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin/'s lymphoma
Bone Marrow Transplantation, 06/27/2012
Crocchiolo R et al. – Tandem Transplantation Is Feasible In High–Risk Non–Hodgkin’s Lymphoma (NHL) Patients Having A HLA–Identical Donor. This Approach Could Represent A Suitable Therapeutic Option For Those Patients With High–Risk NHL Potentially Benefitting From Further Therapy After Auto–SCT. Donor Searches Should Be Started Promptly Whenever Such An Approach Is Chosen.



